CN105476903A - Folic acid toothpaste - Google Patents
Folic acid toothpaste Download PDFInfo
- Publication number
- CN105476903A CN105476903A CN201510920614.6A CN201510920614A CN105476903A CN 105476903 A CN105476903 A CN 105476903A CN 201510920614 A CN201510920614 A CN 201510920614A CN 105476903 A CN105476903 A CN 105476903A
- Authority
- CN
- China
- Prior art keywords
- extract
- folic acid
- extractum
- pulverize
- condensed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 155
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 78
- 239000011724 folic acid Substances 0.000 title claims abstract description 78
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 77
- 229960000304 folic acid Drugs 0.000 title claims abstract description 77
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 60
- 239000000606 toothpaste Substances 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 claims abstract description 197
- 239000002674 ointment Substances 0.000 claims abstract description 27
- 229940094952 green tea extract Drugs 0.000 claims abstract description 24
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 24
- 230000000694 effects Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 239000011159 matrix material Substances 0.000 claims abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 84
- 241000628997 Flos Species 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- 238000000605 extraction Methods 0.000 claims description 42
- 239000012535 impurity Substances 0.000 claims description 42
- 238000003809 water extraction Methods 0.000 claims description 42
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 239000000758 substrate Substances 0.000 claims description 30
- 239000012567 medical material Substances 0.000 claims description 28
- 241001597008 Nomeidae Species 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000008367 deionised water Substances 0.000 claims description 18
- 229910021641 deionized water Inorganic materials 0.000 claims description 18
- 240000007817 Olea europaea Species 0.000 claims description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 15
- 241000180649 Panax notoginseng Species 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 13
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 12
- 235000002725 Olea europaea Nutrition 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000000600 sorbitol Substances 0.000 claims description 12
- 235000010356 sorbitol Nutrition 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000000576 food coloring agent Substances 0.000 claims description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 9
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000004088 foaming agent Substances 0.000 claims description 6
- 235000013922 glutamic acid Nutrition 0.000 claims description 6
- 239000004220 glutamic acid Substances 0.000 claims description 6
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 244000299461 Theobroma cacao Species 0.000 claims description 5
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 5
- 125000004185 ester group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 claims description 5
- 235000013599 spices Nutrition 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 4
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 4
- 229940109275 cyclamate Drugs 0.000 claims description 4
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 4
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 4
- 229920013818 hydroxypropyl guar gum Polymers 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 125000000185 sucrose group Chemical group 0.000 claims description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims description 3
- 229910021532 Calcite Inorganic materials 0.000 claims description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 108010016626 Dipeptides Proteins 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 235000019502 Orange oil Nutrition 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- 229940043350 citral Drugs 0.000 claims description 3
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 claims description 3
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 claims description 3
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 3
- 229940089454 lauryl aldehyde Drugs 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 3
- 239000010502 orange oil Substances 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 3
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 3
- 235000012141 vanillin Nutrition 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 239000009637 wintergreen oil Substances 0.000 claims description 3
- 206010016326 Feeling cold Diseases 0.000 claims description 2
- 230000002528 anti-freeze Effects 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 2
- 238000005202 decontamination Methods 0.000 claims description 2
- 230000003588 decontaminative effect Effects 0.000 claims description 2
- 238000005187 foaming Methods 0.000 claims description 2
- 239000013521 mastic Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 229940117960 vanillin Drugs 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 abstract description 25
- 230000008673 vomiting Effects 0.000 abstract description 18
- 206010047700 Vomiting Diseases 0.000 abstract description 17
- 208000007565 gingivitis Diseases 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 201000001245 periodontitis Diseases 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 208000007117 Oral Ulcer Diseases 0.000 abstract description 6
- 230000001680 brushing effect Effects 0.000 abstract description 6
- 206010057974 epulis Diseases 0.000 abstract description 5
- 208000024693 gingival disease Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 206010006326 Breath odour Diseases 0.000 abstract description 3
- 206010018275 Gingival atrophy Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 208000002925 dental caries Diseases 0.000 abstract description 3
- 201000005562 gingival recession Diseases 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 37
- 208000007502 anemia Diseases 0.000 description 22
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 19
- 229940011671 vitamin b6 Drugs 0.000 description 18
- 235000019158 vitamin B6 Nutrition 0.000 description 17
- 239000011726 vitamin B6 Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 239000012467 final product Substances 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 210000000214 mouth Anatomy 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 244000178870 Lavandula angustifolia Species 0.000 description 9
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000010642 eucalyptus oil Substances 0.000 description 9
- 229940044949 eucalyptus oil Drugs 0.000 description 9
- 239000010678 thyme oil Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 206010028813 Nausea Diseases 0.000 description 6
- 230000001605 fetal effect Effects 0.000 description 6
- 230000008693 nausea Effects 0.000 description 6
- 208000002399 aphthous stomatitis Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- UOELMDIOCSFSEN-FVZZCGLESA-N 7-Dehydrositosterol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)C=C[C@H](C)C(C)C)=CC=C1C[C@@H](O)CCC1=C.C1[C@@H](O)CCC2(C)C(CC[C@@]3([C@@H]([C@H](C)C=C[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 UOELMDIOCSFSEN-FVZZCGLESA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 210000004195 gingiva Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- RMDJVOZETBHEAR-LQYWTLTGSA-N vitamin D5 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C RMDJVOZETBHEAR-LQYWTLTGSA-N 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 210000004916 vomit Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 208000024283 Gingival haemorrhages Diseases 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000037123 dental health Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000008151 pyridoxamine Nutrition 0.000 description 2
- 239000011699 pyridoxamine Substances 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241001506940 Alpinia japonica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010016818 Fluorosis Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000009233 Morning Sickness Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000034850 Vomiting in pregnancy Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000431 corpus luteum hormone Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000004042 dental fluorosis Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940095688 toothpaste product Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of daily chemical products and relates to a folic acid toothpaste, comprising materials of following parts by weight: 1-9 parts of Herba Perillae extract, 1-8 parts of Rhizoma Atractylodis Macrocephalae extract, 0-1 part, but not equal to 0, of Radix Scutellariae extract, 1-5 parts of green tea extract, 2-9 parts of folic acid and its derivatives, and 75-90 parts of ointment matrix. The folic acid toothpaste has the effects such as easing pain and stopping blood, subsiding swelling, inhibiting germs and subsiding inflammations, can be used to effectively prevent a pregnant woman from vomiting during tooth brushing and effectively control pregnancy gingivitis, pregnancy epulis, periodontitis, gingival atrophy, oral ulcers, bad breath, dental decay and the like, has a quick absorption function practiced by using oral sublingual mucosa and can promote the human body to absorb ingredients such as folic acid and give effects of the folic acid to play.
Description
Technical field
The invention belongs to filed of daily-use chemical industry, relate to a kind of daily toothpaste, particularly relate to when one can effectively prevent anemia of pregnant woman from brushing teeth and vomit, effective prevention and pregnancy gingivitis of releiving, gestational epulis, periodontitis, and effectively realize Supplement of folic acid, and medicated toothpaste-anemia of pregnant woman's toothpaste of the disease such as decayed tooth, oral ulcer; The present invention also relates to the preparation technology of this toothpaste special for pregnant women simultaneously.
Background technology
Toothpaste is cleaning supplies conventional in daily life, has very long history.Along with the development of science and technology, technological equipment update and perfect, various types of toothpaste is come out one after another, quality and the class of product improve constantly, present toothpaste variety by single clean type toothpaste, develops into great variety of goods, diverse in function, the Mobyneb toothpaste of up to a hundred brands, meets the needs of different levels level of consumption.But, due to usually fluorine-containing in toothpaste, fluorine use is excessive easily causes fluorosis, therefore, common toothpaste with fluoride is not also suitable for the special population such as anemia of pregnant woman, baby, meanwhile, because the health that women's pregnancy period is special makes tooth paste product in the market can not meet comprehensive demand of pregnant women.
Anemia of pregnant woman selects the reactions such as food, inappetence, mild nausea, vomiting, dizziness, body be tired for about 6 weeks in gestation, is called morning sickness, also claims vomiting during pregnancy.Phenolics, anemia of pregnant woman vomits because of responsive, easily stimulates nauseant nerve when brushing teeth, very easily nauseating, vomiting.Cause a lot of anemia of pregnant woman to remove because of gestation reaction the process of brushing teeth from, like that only can increase the risk of periodontal, having had a strong impact on health and the mouth care of anemia of pregnant woman's tooth, is all disadvantageous to anemia of pregnant woman and fetus.
The gingivitis of phenolics refers to that gingiva is rubescent, swelling, hemorrhage, halitosis, and time serious, loosening appears in tooth, pain, drifting tooth, and a point puerperium symptom alleviates gradually or disappears.Therefore pregnancy gingivitis is referred to as again.Pregnancy gingivitis is the common a kind of oral disease of pregnant woman, and unfavorable to the physical and mental health of anemia of pregnant woman, the anemia of pregnant woman of the clinical 30%-100% of having is affected.
There is abnormal flavour in the common anemia of pregnant woman oral cavity of pregnancy duration, gingival hemorrhage, swelling, even forms epulis.Epulis or form periodontal pocket between swelling gingiva and tooth, wherein caulked food debris, is conducive to the nourishing breeding of bacterial micro-organism, affects health and the prenatal and postnatal care of anemia of pregnant woman.But nearly all anemia of pregnant woman worries, Drug therapy untoward reaction affects the normal development of fetus, and gingivitis can not effectively be controlled.Gingivitis is that anemia of pregnant woman changes due to endocrine the phasic Chang occurred in trimester of pregnancy.Trimester of pregnancy anemia of pregnant woman body inner estrogen and progesterone level all have increase, and progestogen can reduce the generation of collagen, and gingiva substrate is died down.Estrogen then can stimulate swelling and aching of gum.In Early placental phase anemia of pregnant woman body, chorionic-gonadotropin hormone obviously increases, and can affect the integrity of gingival epithelium tissue, and pregnancy gingivitis is the most serious before the pregnant 2-3 month and childbirth.
The reason that pregnant gingivitis occurs mainly affects by estrogen, corpus luteum hormone imbalance etc., and endocrine changes, and makes the metabolism of tissue influenced, thus have also been changed the reaction of gingiva to bacterial plaque.Dental health is good, and do not have local excitation, the inflammation of gingiva tissue will very gently or not occur.In addition, from parent, not only will absorb various nutrition phenolics fetus, also will absorb the various trace element such as calcium, phosphorus, ferrum of q.s from parent, especially will pay attention to supplementary calcium, phosphorus, vitamin D etc.If supplement not enough, the calcium in parent skeleton and tooth, will dissociate out enters blood, with the form of blood calcium supply fetus.Therefore, parent also can produce whole body osteoporosis, and decalcification phenomenon appears in tooth, reduces the acid resistance of tooth, very easily dental caries occurs.In view of this, phenolics and a period of time in puerperal carry out oral cavity health and are very important.
Gravidic first trimester is the important period that embryo's neurocele is grown, determine that embryo's neurocele grows the important period whether perfected, if the lower meeting of folate content causes embryo's neurocele developmental disorder in pregnant women body, this is a kind of lifelong participation disease, can only by preventing to be intervened in advance, and cannot treat after ill, once ill meeting causes repent forever to patient and family members thereof, therefore, the Supplement of folic acid of current pregnant women is also a vital task, existing comparatively general mode is oral YESUAN PIAN, pregnant women is needed to carry with medicine, and take on time, easily there is the phenomenon missed, be unfavorable for effectively supplementing of folic acid.
Toothpaste is articles for daily use indispensable during people live, and the quality of tooth also directly affects health; Medicated toothpaste is in the market of a great variety, differs from one another.But the toothpaste special for anemia of pregnant woman is few, the present invention is directed to anemia of pregnant woman's design, safety non-toxic, has no side effect, and effectively alleviates when anemia of pregnant woman brushes teeth and easily vomits situation, control pregnancy gingivitis, periodontitis, effective Supplement of folic acid, and prevents decayed tooth, the diseases such as anti-treating dental ulcer.
Summary of the invention
One is the object of the present invention is to provide to have preventing or arresting vomiting, pain relieving, hemostasis, detumescence, antibacterial, antiinflammatory, Supplement of folic acid, antiallergic, the folic acid toothpaste of whitening function.
For this reason, the invention provides a kind of folic acid toothpaste, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 1-9 part; Rhizoma Atractylodis Macrocephalae extract 1-8 part; Radix Scutellariae extract 0-1 part, and be not equal to 0; Green tea extract 1-5 part; Folic acid and derivant 2-9 part thereof; Ointment is with substrate 75-90 part.
Preferably, described folic acid toothpaste, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 3-6 part; Rhizoma Atractylodis Macrocephalae extract 3-5 part; Radix Scutellariae extract 0.2-0.8 part; Green tea extract 2-4 part; Folic acid and derivant 4-6 part thereof; Ointment is with substrate 80-85 part.
Preferably, described folic acid toothpaste, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 5 parts; Rhizoma Atractylodis Macrocephalae extract 4 parts; Radix Scutellariae extract 0.5 part; Green tea extract 3 parts; Folic acid and derivant 5 parts thereof; Ointment substrate 83 parts.
Preferably, described folic acid toothpaste, described folic acid toothpaste also comprises the raw material of following weight portion:
Preferably, described folic acid toothpaste, described folic acid toothpaste comprises the raw material of following weight portion:
Preferably, described folic acid toothpaste, to be weight percentage benchmark with matrix weight, described substrate comprises:
Abrasivus 15%-50%;
Sweeting agent 0-1%;
Foaming agent 1%-5%;
Adhesive 0.5%-3%;
Wetting agent 5%-30%;
Spice 0-2%;
Antiseptic 0-0.5%;
Deionized water 2%-40%;
Food coloring 0-1.5%.
Preferably, described folic acid toothpaste, described abrasivus fineness is moderate, pH value is 7.5-9, free from admixture, be selected from calcium carbonate, calcium phosphate dibasic dihydrate, calcium phosphate dibasic anhydrous, calcium pyrophosphate, anhydride silica, aluminium hydroxide, Alumina hydrate, calcite in powder, leuchtenbergite, the granularity of described abrasivus is 5-40 μm, and Mohs' hardness is 2-4 degree;
Described sweeting agent is selected from sucrose, glucide, cyclamate, xylitol, dipeptide sodium;
Described foaming agent has foaming decontamination, is selected from sodium lauryl sulphate, N-sodium lauroyl sarcosine, methyl cocoa ester group sodium taurocholate, acyl glutamic acid sodium;
Described adhesive is primary raw material, and pH value is 8, and its consumption is directly proportional to abrasivus, is selected from sodium alginate, carboxymethyl cellulose, hydroxyethyl-cellulose, yellow gummy powder, hydroxypropyl guar gum;
Described wetting agent has water suction antifreeze and ensure that mastic displays rear indeformable effect, is selected from glycerol, sorbitol, propylene glycol, Polyethylene Glycol;
Described spice is for can make people's feeling cool tasty and refreshing, and the major ingredient of fragrant odour, is selected from lemon sesame oil, Oleum Menthae Rotundifoliae, orange oil, mandarin oil, wintergreen oil, Oleum Anisi Stellati, Borneolum Syntheticum, citral, lauryl aldehyde, vanillin, pentyl acetate;
Described antiseptic is selected from p-Hydroxybenzoate, sodium benzoate, potassium sorbate, sorbitol;
Described deionized water is the plastic disperse medium of toothpaste; Described food coloring is green and purple.
Preferably, described folic acid toothpaste, described abrasivus is calcium carbonate or calcium phosphate dibasic dihydrate; Described sweeting agent is sucrose or xylitol; Described foaming agent is sodium lauryl sulphate; Described adhesive is carboxymethyl cellulose; Described wetting agent is glycerol; Described antiseptic is sorbitol.
Preferably, in described folic acid toothpaste,
Described Folium perillae extract is that pulverize, water extraction or alcohol extraction, be condensed into extractum or Folium Perillae volatile oil component that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium Perillae medical material removing impurity;
Described Rhizoma Atractylodis Macrocephalae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Rhizoma Atractylodis Macrocephalae removing impurity;
Described Radix Scutellariae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected radix scutellariae medicinal materials removing impurity;
Described green tea extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected green tea medical material removing impurity.
Preferably, described folic acid toothpaste,
Described notoginseng extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Radix Notoginseng medical material removing impurity;
Described Radix Glycyrrhizae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected licorice medicinal materials removing impurity;
Described Flos Lonicerae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Chinese medicine honeysuckle removing impurity;
Described Flos Sophorae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Sophorae medical material removing impurity;
Described Folium Menthae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Herba Menthae medical material removing impurity;
Described Fructus Fragariae Ananssae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Fructus Fragariae Ananssae removing impurity;
Described Flos Inulae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Inulae medical material removing impurity;
Described Flos Chrysanthemi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Chrysanthemi medical material removing impurity;
Described Olive leaf P.E is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium olive medical material removing impurity;
Described Cortex Cinnamomi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Cortex Cinnamomi medical material removing impurity.
Folium Perillae is the dry stem of Labiatae Folium Perillae Perillafrutescens (L) Britt, has another name called Huis Soviet Union, red Soviet Union, purple Soviet Union, red Soviet Union, Fructus Perillae etc.Have special fragrance, China's cultivation is extremely wide, is mainly used in medicinal, oil use, spice, the aspect such as edible, its leaf, stalk, really all can be used as medicine, and tender leaf can be eaten raw, cook soup, and stem and leaf can be pickled.Being used as medicine, it is warm in nature, acrid in the mouth, and can induce sweat cold expelling, relieving QI stagnancy in the stomach, rushes down the diseases such as poisoning for anemofrigid cold, cough vomiting and nausea, vomiting during pregnancy, fish.Modern pharmacological research shows: Folium Perillae also has antibacterial, antiviral, blood pressure lowering, blood fat reducing, suppresses platelet aggregation, antithrombotic, defying age, fat-reducing, anti-allergic inflammation, enhancing learning and memory, function such as prevention canceration and inhibition tumor cell transfer etc.For many years, Folium Perillae is widely used in medicine, food with its integration of edible and medicinal herbs.Because Folium Perillae (stalk) medical material has regulating the flow of QI to ease the stomach, pain relieving, antiabortive effect, also has antibacterial, antiviral, blood pressure lowering, blood fat reducing, suppresses platelet aggregation, antithrombotic, defying age, fat-reducing, anti-allergic inflammation; The Rhizoma Atractylodis Macrocephalae can invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, and antiabortive, for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, and frequent fetal movement can be used for again antiabortive, controls the diseases such as gestation foot is swollen, nausea is uneasy; Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.For hygropyrexia, heat-damp in summer, vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, lung-heat coughs element, high hot excessive thirst, and heat in blood tells nosebleed, carbuncle sore tumefacting virus, frequent fetal movement; With the extract of Folium Perillae (stalk), the Rhizoma Atractylodis Macrocephalae, Radix Scutellariae, vitamin B6 be sole active pharmaceutical composition be prepared from folic acid toothpaste, vomiting when can prevent anemia of pregnant woman from brushing teeth, at prevention and pregnancy gingivitis of releiving, periodontitis, and decayed tooth, oral ulcer, the aspects such as mouth care have significant effect.
The Rhizoma Atractylodis Macrocephalae is the dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae AtractylodesmacrocephalaKoidz..Have another name called mountain Ji, poplar robe Ji, yellor rocket, sky Ji, Alpinia japonica (Thunb.) Miq., QI LI JIA, Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis Macrocephalae, the winter Rhizoma Atractylodis Macrocephalae, white birthday etc., property is bitter, sweet, temperature.Return spleen, stomach warp.Be mainly used in invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.
1., for weakness of the spleen and stomach, lack of appetite distension, fatigue and weakness, has loose bowels.Tonifying the spleen and stomach can with the compatibility such as Radix Codonopsis, Radix Glycyrrhizae; The painful abdominal mass that disappears de-swelling can be equal to Fructus Aurantii to be used; The spleen strengthening and damp drying antidiarrheal can be equal to Pericarpium Citri Reticulatae, Poria to be used.
2. for water-damp retention, phlegm retention, edema.Control cold fluid-retention can with the compatibility such as Poria, Ramulus Cinnamomi; Harnessing the river swells often to be equal to Cortex Sclerotii Poriae, Pericarpium Arecae uses.
3. for exterior deficiency spontaneous perspiration.This product is equal to use with the Radix Astragali, Fructus Tritici Levis, has the merit of strengthening superficial resistance to stop perspiration, can control exterior deficiency spontaneous perspiration.
In addition, this product can be used for again antiabortive, controls the diseases such as gestation foot is swollen, nausea is uneasy, the person that has interior-heat, can with the compatibility such as Radix Scutellariae; Soreness of waist person can be equal to the Cortex Eucommiae, Herba Taxilli and uses.The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive effect.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement." medicine origin " is recorded: " dehumidifying benefit is dry, and middle QI invigorating, warming middle-JIAO, go in taste wet, except gastric heat, strong taste, enter diet, quench the thirst, antiabortive.”
" the deficient Chinese angelica powder opinion of danxi's experiential therapy gold " of " the Radix Scutellariae Rhizoma Atractylodis Macrocephalae is antiabortive panacea "-come from ZHU Dan-xi.
Radix Scutellariae is the dry root of labiate Radix Scutellariae ScutellariabaicalensisGeorgi.Conically, distortion, long 8 ~ 25cm, diameter 1 ~ 3cm.Surface brown color or buff, have sparse excipuliform radicula trace, top is more coarse, and have the vertical wrinkle of distortion or irregular reticulate pattern, rift grain and scabriculous are arranged at bottom.Matter is hard and crisp, frangibility, and section is yellow, and middle rufous, is generally called sub-a kind of reed mentioned in ancient books, based on yin nourishing of relieving inflammation or internal heat; In burgundy or brownish black in the middle of old root, dry and decayed shape or become cavity, claims Radix Scutellariae, relieves internal heat to relieve inflammation or internal heat.Feeble QI, bitter in the mouth.Return lung, gallbladder, spleen, large intestine, small intestine meridian.Function heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive, blood pressure lowering.For hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst, heat in blood tells nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.Radix Scutellariae is also usually used in treating gynecological disorders, has the function of clearing heat and preventing abortion, can control the frequent fetal movement that heat is very caused, habitual abortion.Control the effects such as vomiting during pregnancy.
Vitamin B6 (VitaminB6) is also known as pyridoxin, and a kind of vitamin B group containing pyridoxol or 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine. or pyridoxamine, it is water soluble vitamins, meets light or alkali destructible, non-refractory.Vitamin B6 is clear crystal, soluble in water and ethanol, and stable in acid solution, destructible in alkali liquor, pyridoxol is heat-resisting, 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine. and pyridoxamine non-refractory.Vitamin B6 content in yeast, liver, grain, meat, fish, egg, beans and Semen arachidis hypogaeae is more.Vitamin B6 is the constituent of some coenzyme in human body, participates in multiple metabolic response, especially has substantial connection with amino acid metabolism.Apply Vitamin B6 preparation control vomiting during pregnancy and radiation sickness vomiting clinically.
Except above-mentioned Chinese crude drug, also can add Rhizoma Zingiberis Recens, Fructus Citri Sarcodactylis, Radix Ophiopogonis, Radix Rehmanniae, Caulis Bambusae In Taenia, Fructus Amomi, Herba Taxilli, the Cortex Eucommiae, Radix Dipsaci, Radix Boehmeriae, Folium Artemisiae Argyi, Semen Cuscutae, Colla Corii Asini, Rhizoma Acori Graminei, Fructus Vitis viniferae, Fructus Citri Limoniae etc. in toothpaste of the present invention in order to prevent vomiting during pregnancy, control pregnancy gingivitis and to anemia of pregnant woman's all medicinal substances extract active component without any side effects.With extract, the common conduct of the vitamin B6 mainly pharmaceutically active substance of Folium Perillae (stalk), the Rhizoma Atractylodis Macrocephalae, radix scutellariae medicinal materials, various efficacy of drugs is made to produce synergism, thus more effectively prevent and treat gestational gingival hemorrhage, gingivitis, periodontitis, the disease such as gingival atrophy and oral ulcer, utilizes oral cavity hypoglossis mucous membrane to have the function absorbed fast simultaneously, promote that human body is to the absorption of the compositions such as folic acid, plays folic acid effect.
Detailed description of the invention
Prepared by raw material:
Described Folium perillae extract is that pulverize, water extraction or alcohol extraction, be condensed into extractum or Folium Perillae volatile oil component that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium Perillae medical material removing impurity.
Described Rhizoma Atractylodis Macrocephalae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Rhizoma Atractylodis Macrocephalae removing impurity.
Described Radix Scutellariae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected radix scutellariae medicinal materials removing impurity.
Described green tea extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected green tea medical material removing impurity.
Described notoginseng extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Radix Notoginseng medical material removing impurity.
Described Radix Glycyrrhizae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected licorice medicinal materials removing impurity.
Described Flos Lonicerae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Chinese medicine honeysuckle removing impurity.
Described Flos Sophorae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Sophorae medical material removing impurity.
Described Folium Menthae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Herba Menthae medical material removing impurity.
Described Fructus Fragariae Ananssae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Fructus Fragariae Ananssae removing impurity.
Described Flos Inulae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Inulae medical material removing impurity.
Described Flos Chrysanthemi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Chrysanthemi medical material removing impurity.
Described Olive leaf P.E is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium olive medical material removing impurity.
Described Cortex Cinnamomi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Cortex Cinnamomi medical material removing impurity.
Toothpaste substrate: be commercially available prod.
Embodiment 1
Take Folium perillae extract 1g, Rhizoma Atractylodis Macrocephalae extract 8g, Radix Scutellariae extract 0.1g, green tea extract 5g, folic acid and derivant 2g thereof, calcium carbonate 45g, dipeptide sodium 0.9g, sodium lauryl sulphate 0.9g, sodium alginate 2.7g, Polyethylene Glycol 4.5g, lemon sesame oil 1.8g, deionized water 32.85g, non-polluted edible pigment 1.35g, mix homogeneously, is placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.
Embodiment 2
Take Folium perillae extract 9g, Rhizoma Atractylodis Macrocephalae extract 1g, Radix Scutellariae extract 1g; green tea extract 1g, folic acid and derivant 9g thereof, leuchtenbergite 11.25g; acyl glutamic acid sodium 3.75g, hydroxypropyl guar gum 1.875g, glycerol 26.25g; pentyl acetate 1.5g; p-Hydroxybenzoate 0.375g, deionized water 30g, mix homogeneously; be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.
Embodiment 3
Take Folium perillae extract 3g, Rhizoma Atractylodis Macrocephalae extract 5g, Radix Scutellariae extract 0.2g, green tea extract 4g, folic acid and derivant 4g thereof, ointment substrate 85g, calcium phosphate dibasic anhydrous 42.5g, cyclamate 0.85g, N-sodium lauroyl sarcosine 4.25g, yellow gummy powder 2.55g, sorbitol 29.75g, Oleum Menthae Rotundifoliae 1.7g, sodium benzoate 0.425g, deionized water 1.7g, non-polluted edible pigment 1.275g, mix homogeneously, is placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.
Embodiment 4
Take Folium perillae extract 6g, Rhizoma Atractylodis Macrocephalae extract 3g, Radix Scutellariae extract 0.8g; green tea extract 2g, folic acid and derivant 6g thereof, calcite in powder 28g; glucide 0.4g, methyl cocoa ester group sodium taurocholate 2.4g, carboxymethyl cellulose 0.4g; propylene glycol 20g, vanillin 0.8g, potassium sorbate 0.24g; deionized water 26.96g, purple food coloring 0.8g, mix homogeneously; be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.
Embodiment 5
Take Folium perillae extract 5g, Rhizoma Atractylodis Macrocephalae extract 4g, Radix Scutellariae extract 0.5g, green tea extract 3g, folic acid and derivant 5g thereof, ointment substrate 83g, calcium pyrophosphate 41.5g, xylitol 0.83g, sodium lauryl sulphate 4.15g, hydroxyethyl-cellulose 2.49g, sorbitol 24.9g, lauryl aldehyde 1.66g, potassium sorbate 0.415g, deionized water 5.81g, non-polluted edible pigment 1.245g, mix homogeneously, is placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.
Embodiment 6
Take Folium perillae extract 1g, Rhizoma Atractylodis Macrocephalae extract 8g, Radix Scutellariae extract 0.1g, green tea extract 5g, folic acid and derivant 2g thereof, notoginseng extract 1g, Radix Glycyrrhizae extract 10g, Flos Lonicerae extract 1g, Flos Sophorae extract 4g, Folium Menthae extract 0.1g, Fructus Fragariae Ananssae extract 4g, Flos Inulae extract 2g, Flos Chrysanthemi extract 6g, Olive leaf P.E 2g, Oleum lavandula angustifolia quintessence oil 1g, Oleum Caryophylli 0.1g, Eucalyptus oil 2g, thyme oil 2g, Cortex Cinnamomi extract 6g, vitamin B6 0.1g, vitamin D1 0g, ointment substrate 90g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: Alumina hydrate 15%, sucrose 1%, methyl cocoa ester group sodium taurocholate 5%; hydroxypropyl guar gum 3%, Polyethylene Glycol 35%, orange oil 2%; sorbitol 0.5%, deionized water 37%, purple food coloring 1.5%.
Embodiment 7
Take Folium perillae extract 9g, Rhizoma Atractylodis Macrocephalae extract 1g, Radix Scutellariae extract 1g, green tea extract 1g, folic acid and derivant 9g thereof, notoginseng extract 8g, Radix Glycyrrhizae extract 1g, Flos Lonicerae extract 4g, Flos Sophorae extract 2g, Folium Menthae extract 1g, Fructus Fragariae Ananssae extract 2g, Flos Inulae extract 8g, Flos Chrysanthemi extract 2g, Olive leaf P.E 6g, Oleum lavandula angustifolia quintessence oil 0.1g, Oleum Caryophylli 1g, Eucalyptus oil 1g, thyme oil 6g, Cortex Cinnamomi extract 2g, vitamin B6 2g, vitamin D1 g, ointment substrate 75g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: anhydride silica 50%, glucide 0.5%, acyl glutamic acid sodium 1%; yellow gummy powder 0.5%, glycerol 5%, citral 2%; p-Hydroxybenzoate 0.5%, deionized water 39%, purple food coloring 1.5%.
Embodiment 8
Take Folium perillae extract 3g, Rhizoma Atractylodis Macrocephalae extract 5g, Radix Scutellariae extract 0.2g, green tea extract 4g, folic acid and derivant 4g thereof, notoginseng extract 8g, Radix Glycyrrhizae extract 1g, Flos Lonicerae extract 4g, Flos Sophorae extract 2g, Folium Menthae extract 1g, Fructus Fragariae Ananssae extract 2g, Flos Inulae extract 8g, Flos Chrysanthemi extract 2g, Olive leaf P.E 6g, Oleum lavandula angustifolia quintessence oil 0.1g, Oleum Caryophylli 1g, Eucalyptus oil 1g, thyme oil 6g, Cortex Cinnamomi extract 2g, vitamin B6 2g, vitamin D1 g, ointment substrate 85g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: aluminium hydroxide 45%, cyclamate 1%, N-sodium lauroyl sarcosine 1%, yellow gummy powder 3%, sorbitol 30%, mandarin oil 1%, sodium benzoate 0.5%, deionized water 17.5%, non-polluted edible pigment 1%.
Embodiment 9
Take Folium perillae extract 6g, Rhizoma Atractylodis Macrocephalae extract 3g, Radix Scutellariae extract 0.8g, green tea extract 2g, folic acid and derivant 6g thereof, notoginseng extract 1g, Radix Glycyrrhizae extract 10g, Flos Lonicerae extract 1g, Flos Sophorae extract 4g, Folium Menthae extract 0.1g, Fructus Fragariae Ananssae extract 4g, Flos Inulae extract 2g, Flos Chrysanthemi extract 6g, Olive leaf P.E 2g, Oleum lavandula angustifolia quintessence oil 1g, Oleum Caryophylli 0.1g, Eucalyptus oil 2g, thyme oil 2g, Cortex Cinnamomi extract 6g, vitamin B6 0.1g, vitamin D1 0g, ointment substrate 80g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: calcium pyrophosphate 15.4%, glucide 0.1%, methyl cocoa ester group sodium taurocholate 3%; carboxymethyl cellulose 3%, propylene glycol 35%, Borneolum Syntheticum 2%; potassium sorbate 0.5%, deionized water 40%, purple food coloring 1%.
Embodiment 10
Take Folium perillae extract 5g, Rhizoma Atractylodis Macrocephalae extract 4g, Radix Scutellariae extract 0.5g, green tea extract 3g, folic acid and derivant 5g thereof, notoginseng extract 5g, Radix Glycyrrhizae extract 5g, Flos Lonicerae extract 2.5g, Flos Sophorae extract 2.5g, Folium Menthae extract 0.5g, Fructus Fragariae Ananssae extract 3g, Flos Inulae extract 5g, Flos Chrysanthemi extract 4g, Olive leaf P.E 4g, Oleum lavandula angustifolia quintessence oil 0.5g, Oleum Caryophylli 0.5g, Eucalyptus oil 1.5g, thyme oil 4g, Cortex Cinnamomi extract 4g, vitamin B6 1g, Vitamin D5. g, ointment substrate 83g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: (granularity is 25 μm to calcium phosphate dibasic dihydrate; Mohs' hardness is 3 degree) 30%; glucide 0.5%; acyl glutamic acid sodium 3%, yellow gummy powder 2%, glycerol 35%; Oleum Anisi Stellati 1%; p-Hydroxybenzoate 0.25%, deionized water 27.25%, purple food coloring 1%.
Embodiment 11
Take Folium perillae extract 4g, Rhizoma Atractylodis Macrocephalae extract 6g, Radix Scutellariae extract 0.2g, green tea extract 4g, folic acid and derivant 3g thereof, notoginseng extract 2g, Radix Glycyrrhizae extract 8g, Flos Lonicerae extract 2g, Flos Sophorae extract 3.8g, Folium Menthae extract 0.2g, Fructus Fragariae Ananssae extract 3.8g, Flos Inulae extract 4g, Flos Chrysanthemi extract 5g, Olive leaf P.E 3g, Oleum lavandula angustifolia quintessence oil 0.8g, Oleum Caryophylli 0.1g, Eucalyptus oil 1.9g, thyme oil 2.5g, Cortex Cinnamomi extract 5g, folic acid and phase derivant 0.3g, vitamin B6 1.8g, vitamin D 8g, ointment substrate 87g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: (granularity is 5 μm to calcium phosphate dibasic dihydrate; Mohs' hardness is 4 degree) 32%; glucide 1%; acyl glutamic acid sodium 5%, yellow gummy powder 3%, glycerol 20%; wintergreen oil 2%; p-Hydroxybenzoate 0.5%, deionized water 35%, purple food coloring 1.5%.
Embodiment 12
Take Folium perillae extract 7g, Rhizoma Atractylodis Macrocephalae extract 2g, Radix Scutellariae extract 0.6g, green tea extract 2g, folic acid and derivant 8g thereof, notoginseng extract 4g, Radix Glycyrrhizae extract 4g, Flos Lonicerae extract 3g, Flos Sophorae extract 2.6g, Folium Menthae extract 0.7g, Fructus Fragariae Ananssae extract 2.2g, Flos Inulae extract 7g, Flos Chrysanthemi extract 3g, Olive leaf P.E 5g, Oleum lavandula angustifolia quintessence oil 0.2g, Oleum Caryophylli 0.7g, Eucalyptus oil 1.3g, thyme oil 5g, Cortex Cinnamomi extract 3g, folic acid and phase derivant 1.7g, vitamin B6 0.2g, vitamin D 8g, ointment substrate 78g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: (granularity is 40 μm to calcium carbonate, Mohs' hardness is 2 degree) 20%, sucrose or xylitol 1%, sodium lauryl sulphate 3%, carboxymethyl cellulose 3%, glycerol 30%, Oleum Anisi Stellati 2%, sorbitol 0.5%, deionized water 40%, non-polluted edible pigment 0.5%.
Embodiment 13
Take Folium perillae extract 5g, Rhizoma Atractylodis Macrocephalae extract 4g, Radix Scutellariae extract 0.4g, green tea extract 3g, folic acid and derivant 4.5g thereof, notoginseng extract 3g, Radix Glycyrrhizae extract 6g, Flos Lonicerae extract 2.5g, Flos Sophorae extract 3.3g, Folium Menthae extract 0.5g, Fructus Fragariae Ananssae extract 3g, Flos Inulae extract 5g, Flos Chrysanthemi extract 4g, Olive leaf P.E 4g, Oleum lavandula angustifolia quintessence oil 0.5g, Oleum Caryophylli 0.4g, Eucalyptus oil 1.5g, thyme oil 3.5g, Cortex Cinnamomi extract 4g, folic acid and phase derivant 1g, vitamin B6 1g, Vitamin D5. g, ointment substrate 80g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: calcium carbonate 20%, xylitol 1%, sodium lauryl sulphate 5%, carboxymethyl cellulose 0.5%, glycerol 35%, Oleum Anisi Stellati 2%, sorbitol 0.5%, deionized water 35%, non-polluted edible pigment 1%.
Embodiment 14
Take Folium perillae extract 6g, Rhizoma Atractylodis Macrocephalae extract 4g, Radix Scutellariae extract 0.4g, green tea extract 3g, folic acid and derivant 5.5g thereof, notoginseng extract 3g, Radix Glycyrrhizae extract 6g, Flos Lonicerae extract 2.5g, Flos Sophorae extract 3.2g, Folium Menthae extract 0.4g, Fructus Fragariae Ananssae extract 3g, Flos Inulae extract 4g, Flos Chrysanthemi extract 4g, Olive leaf P.E 4g, Oleum lavandula angustifolia quintessence oil 0.5g, Oleum Caryophylli 0.4g, Eucalyptus oil 1.6g, thyme oil 4g, Cortex Cinnamomi extract 4g, folic acid and phase derivant 1g, vitamin B6 1g, Vitamin D5. g, ointment substrate 81g, mix homogeneously, be placed in after vacuum Manufacturing medicine extract machine carries out homogenizing process, fill and get final product.Wherein said ointment substrate is become to be grouped into by following: calcium phosphate dibasic dihydrate 30%, sucrose 1%, sodium lauryl sulphate 1%, carboxymethyl cellulose 0.5%, glycerol 35%, Oleum Anisi Stellati 1%, deionized water 30%, non-polluted edible pigment 1.5%.
Experimental example
Investigate folic acid toothpaste prepared by embodiments of the invention 14 to pregnancy gingivitis, periodontitis, and the disease such as decayed tooth, oral ulcer there is control and the therapeutical effect such as to releive, and is confirmed by following clinical observation.Following table is the clinical observation statistical table of folic acid toothpaste of the present invention.
Patient age 20-38 year, wherein primipara 500 example, multipara 134 example.Symptoms of emesis when all patients all brush teeth.After using folic acid toothpaste of the present invention, symptoms of emesis alleviates all to some extent or alleviates.
Note: same patient can exist multiple disease simultaneously, therefore, the number that total number of persons is greater than actual participation test is normal phenomenon.
Folic acid toothpaste of the present invention, every day uses sooner or later, and toothpaste should stop the slightly longer time compared with ordinary toothpaste in oral cavity, and especially the periodontal time of staying of cacodontia more needs long.As can be seen from the above table, folic acid toothpaste of the present invention has pain easing and hemostasis, detumescence, the effects such as anti-inflammation, can be used for vomiting when effectively preventing anemia of pregnant woman from brushing teeth, effectively prevent and treat pregnancy gingivitis, gestational epulis, periodontitis, gingival atrophy, oral ulcer, halitosis and dental caries etc., utilize oral cavity hypoglossis mucous membrane to have the function absorbed fast simultaneously, promote that human body is to the absorption of the compositions such as folic acid, plays folic acid effect.After using one week, above-mentioned symptom obviously improves, and pregnancy and puerperium uses, without any side effects, and can be used for keeping oral cavity cleaning, pre-preventing tooth diseases occurs, and impels dental health.
Obviously, above-described embodiment is only for clearly example being described, and the restriction not to embodiment.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here exhaustive without the need to also giving all embodiments.And thus the apparent change of extending out or variation be still among the protection domain of the invention.
Claims (10)
1. a folic acid toothpaste, is characterized in that, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 1-9 part; Rhizoma Atractylodis Macrocephalae extract 1-8 part; Radix Scutellariae extract 0-1 part, and be not equal to 0; Green tea extract 1-5 part; Folic acid and derivant 2-9 part thereof; Ointment is with substrate 75-90 part.
2. folic acid toothpaste according to claim 1, is characterized in that, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 3-6 part; Rhizoma Atractylodis Macrocephalae extract 3-5 part; Radix Scutellariae extract 0.2-0.8 part; Green tea extract 2-4 part; Folic acid and derivant 4-6 part thereof; Ointment is with substrate 80-85 part.
3. folic acid toothpaste according to claim 1 and 2, is characterized in that, the raw material comprising following weight portion of described folic acid toothpaste: Folium perillae extract 5 parts; Rhizoma Atractylodis Macrocephalae extract 4 parts; Radix Scutellariae extract 0.5 part; Green tea extract 3 parts; Folic acid and derivant 5 parts thereof; Ointment substrate 83 parts.
4. the folic acid toothpaste according to any one of claim 1-3, is characterized in that, described folic acid toothpaste also comprises the raw material of following weight portion:
5. folic acid toothpaste according to claim 4, is characterized in that: described folic acid toothpaste comprises the raw material of following weight portion:
6. the folic acid toothpaste as described in any one of claim 1-5, is characterized in that: to be weight percentage benchmark with matrix weight, described substrate comprises:
Abrasivus 15%-50%;
Sweeting agent 0-1%;
Foaming agent 1%-5%;
Adhesive 0.5%-3%;
Wetting agent 5%-35%;
Spice 0-2%;
Antiseptic 0-0.5%;
Deionized water 2%-40%;
Food coloring 0-1.5%.
7. folic acid toothpaste according to claim 6, is characterized in that:
Described abrasivus fineness is moderate, pH value is 7.5-9, free from admixture, be selected from calcium carbonate, calcium phosphate dibasic dihydrate, calcium phosphate dibasic anhydrous, calcium pyrophosphate, anhydride silica, aluminium hydroxide, Alumina hydrate, calcite in powder, leuchtenbergite, the granularity of described abrasivus is 5-40 μm, and Mohs' hardness is 2-4 degree;
Described sweeting agent is selected from sucrose, glucide, cyclamate, xylitol, dipeptide sodium;
Described foaming agent has foaming decontamination, is selected from sodium lauryl sulphate, N-sodium lauroyl sarcosine, methyl cocoa ester group sodium taurocholate, acyl glutamic acid sodium;
Described adhesive is primary raw material, and pH value is 8, and its consumption is directly proportional to abrasivus, is selected from sodium alginate, carboxymethyl cellulose, hydroxyethyl-cellulose, yellow gummy powder, hydroxypropyl guar gum;
Described wetting agent has water suction antifreeze and ensure that mastic displays rear indeformable effect, is selected from glycerol, sorbitol, propylene glycol, Polyethylene Glycol;
Described spice is for can make people's feeling cool tasty and refreshing, and the major ingredient of fragrant odour, is selected from lemon sesame oil, Oleum Menthae Rotundifoliae, orange oil, mandarin oil, wintergreen oil, Oleum Anisi Stellati, Borneolum Syntheticum, citral, lauryl aldehyde, vanillin, pentyl acetate;
Described antiseptic is selected from p-Hydroxybenzoate, sodium benzoate, potassium sorbate, sorbitol;
Described deionized water is the plastic disperse medium of toothpaste; Described food coloring is green and purple.
8. folic acid toothpaste according to claim 7, is characterized in that: described abrasivus is calcium carbonate or calcium phosphate dibasic dihydrate; Described sweeting agent is sucrose or xylitol; Described foaming agent is sodium lauryl sulphate; Described adhesive is carboxymethyl cellulose; Described wetting agent is glycerol; Described antiseptic is sorbitol.
9. the folic acid toothpaste according to any one of claim 1-3, is characterized in that,
Described Folium perillae extract is that pulverize, water extraction or alcohol extraction, be condensed into extractum or Folium Perillae volatile oil component that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium Perillae medical material removing impurity;
Described Rhizoma Atractylodis Macrocephalae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Rhizoma Atractylodis Macrocephalae removing impurity;
Described Radix Scutellariae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected radix scutellariae medicinal materials removing impurity;
Described green tea extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected green tea medical material removing impurity.
10. the folic acid toothpaste according to claim 4 or 5, is characterized in that,
Described notoginseng extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Radix Notoginseng medical material removing impurity;
Described Radix Glycyrrhizae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected licorice medicinal materials removing impurity;
Described Flos Lonicerae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Chinese medicine honeysuckle removing impurity;
Described Flos Sophorae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Sophorae medical material removing impurity;
Described Folium Menthae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Herba Menthae medical material removing impurity;
Described Fructus Fragariae Ananssae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Fructus Fragariae Ananssae removing impurity;
Described Flos Inulae extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Inulae medical material removing impurity;
Described Flos Chrysanthemi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Flos Chrysanthemi medical material removing impurity;
Described Olive leaf P.E is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Folium olive medical material removing impurity;
Described Cortex Cinnamomi extract is that pulverize, water extraction or alcohol extraction, be condensed into the extractum that relative density is 1.10-1.30 after concentrated solution activated carbon decolorizing by selected Cortex Cinnamomi medical material removing impurity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510920614.6A CN105476903A (en) | 2015-12-11 | 2015-12-11 | Folic acid toothpaste |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510920614.6A CN105476903A (en) | 2015-12-11 | 2015-12-11 | Folic acid toothpaste |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105476903A true CN105476903A (en) | 2016-04-13 |
Family
ID=55664423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510920614.6A Pending CN105476903A (en) | 2015-12-11 | 2015-12-11 | Folic acid toothpaste |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105476903A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106924162A (en) * | 2017-03-27 | 2017-07-07 | 云南西草资源开发有限公司 | A kind of application of plant additive, bacteriostatic agent, oral care product and plant additive in oral care product is prepared |
CN107362114A (en) * | 2017-08-06 | 2017-11-21 | 何家平 | A kind of sophora flower children's toothpaste |
CN107445163A (en) * | 2017-09-08 | 2017-12-08 | 常州可赛成功塑胶材料有限公司 | A kind of preparation method of bacteriostatic activated carbon |
CN108096486A (en) * | 2018-01-25 | 2018-06-01 | 北京斯利安药业有限公司 | Composition, pelliculae pro cavo oris and preparation method thereof |
CN109330940A (en) * | 2018-11-15 | 2019-02-15 | 广州立白企业集团有限公司 | A kind of graininess breath freshening products and preparation method thereof |
CN110051588A (en) * | 2019-05-10 | 2019-07-26 | 德利宝(广州)香料有限公司 | A kind of preparation method of chamomile mint extract essence and oral cavity composite cream containing the essence |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101947198A (en) * | 2010-09-10 | 2011-01-19 | 甘肃奇正藏药有限公司 | Toothpaste special for pregnant women and preparation process thereof |
CN104922245A (en) * | 2014-03-17 | 2015-09-23 | 王贵琴 | Vitamin-containing Chinese herbal medicine toothpaste |
-
2015
- 2015-12-11 CN CN201510920614.6A patent/CN105476903A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101947198A (en) * | 2010-09-10 | 2011-01-19 | 甘肃奇正藏药有限公司 | Toothpaste special for pregnant women and preparation process thereof |
CN104922245A (en) * | 2014-03-17 | 2015-09-23 | 王贵琴 | Vitamin-containing Chinese herbal medicine toothpaste |
Non-Patent Citations (1)
Title |
---|
陈小芸等: "黄芩全效牙膏的研制与脱敏疗效临床观察", 《牙膏工业》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106924162A (en) * | 2017-03-27 | 2017-07-07 | 云南西草资源开发有限公司 | A kind of application of plant additive, bacteriostatic agent, oral care product and plant additive in oral care product is prepared |
CN106924162B (en) * | 2017-03-27 | 2019-12-06 | 云南西草资源开发有限公司 | Plant additive, bacteriostatic agent, oral care product and application of plant additive in preparation of oral care product |
CN107362114A (en) * | 2017-08-06 | 2017-11-21 | 何家平 | A kind of sophora flower children's toothpaste |
CN107445163A (en) * | 2017-09-08 | 2017-12-08 | 常州可赛成功塑胶材料有限公司 | A kind of preparation method of bacteriostatic activated carbon |
CN108096486A (en) * | 2018-01-25 | 2018-06-01 | 北京斯利安药业有限公司 | Composition, pelliculae pro cavo oris and preparation method thereof |
CN109330940A (en) * | 2018-11-15 | 2019-02-15 | 广州立白企业集团有限公司 | A kind of graininess breath freshening products and preparation method thereof |
CN110051588A (en) * | 2019-05-10 | 2019-07-26 | 德利宝(广州)香料有限公司 | A kind of preparation method of chamomile mint extract essence and oral cavity composite cream containing the essence |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101947198B (en) | Toothpaste special for pregnant women and preparation process thereof | |
CN105476903A (en) | Folic acid toothpaste | |
CN101391011B (en) | Pure Chinese herbal medicine gargle water for treating oral inflammation | |
CN103906526A (en) | Wrap fermentation method using medicinal flower, and composition for external application onto the skin using same | |
CN102525871B (en) | Toothpaste for preventing and treating recurrent aphtha and preparation method | |
CN103156984B (en) | Traditional Chinese medicine composition for treating gingivitis and preparation method thereof | |
CN102370878B (en) | Chinese medicinal oral preparation for treating aphthous stomatitis | |
CN105232911A (en) | Traditional Chinese medicine composition | |
CN101164600A (en) | Medicine for treating acne and whelk | |
CN101264250B (en) | Chinese medicinal composition for treating mouth ulcer | |
CN102670479A (en) | Traditional Chinese medicine antiphlogistic acne-pullout cosmetic cream and preparation method thereof | |
CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
CN104814907A (en) | Toothpaste for treating gingival bleeding | |
CN104524494A (en) | Traditional Chinese medicine composition | |
CN103638260A (en) | Multipurpose traditional Chinese medicine formula and decocting method thereof | |
CN104173699B (en) | A kind of chewable tablets of anti-treating dental ulcer and preparation method thereof | |
CN104367503A (en) | Special tumor chemotherapy toothpaste and preparation method thereof | |
CN101239128B (en) | Menstruation-regulating face-nourishing Chinese medicinal composition and preparation thereof | |
CN104435962A (en) | Pharmaceutical composition for treating dyspeptic diarrhea of piglets and preparation method thereof | |
CN103520054A (en) | Application of uncaria extract in preparation of oral care product | |
CN102266505A (en) | Compound Chinese medicinal oral mucosa repair liquid | |
CN106728683A (en) | Treat medicament, the preparation method and its usage of canker sore | |
CN105287951A (en) | Combination capable of fading color spots and preparation method thereof | |
CN104971212A (en) | Traditional Chinese medicine oral liquid for treating yin deficiency and flaring up of deficient fire, and method for preparing same | |
CN105194258A (en) | Traditional Chinese medicine composition for treating diseases caused by kidney essence deficiency and decoction method of traditional Chinese medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160413 |
|
RJ01 | Rejection of invention patent application after publication |